V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
Tech — Software

GoodRx Holdings Executive Compensation (FY25)

GDRX · Santa Monica, CA · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Wendy Barnes
Median of the other named officers
$971,608
5 officers, excluding the chief executive
Latest say-on-pay support
=
June 16, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in Tech — Software, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on GoodRx Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 19, 2026Latest filing (8-K): June 18, 2026
8 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
GoodRx Holdings brief$1,500Get the executive brief
Velarion Member, one year
263 figures on this page: 259 cited to the filing that reported them, 4 calculated from figures it prints. See the citations

More on GoodRx Holdings

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Scott Wagner → Wendy Barnes

Frequently asked questions

Answers drawn from the data on this page.
Who is GoodRx Holdings' chief executive and what were they paid?
Wendy Barnes was paid $23,367,483 in total compensation as Chief Executive Officer & President for fiscal 2025.
What was GoodRx Holdings' say-on-pay result?
The say-on-pay proposal drew 99.0% of votes cast for or against in favor at the meeting held June 16, 2026 for fiscal 2025.
Which companies are in GoodRx Holdings' peer group?
The disclosed peer group names 23andMe Holding Co., Accolade, Inc., Affirm Holdings, Inc., Alarm.com Holdings, Inc. and Alignment Healthcare, Inc., among others.
What is GoodRx Holdings' chief executive pay ratio?
The company reported a chief executive pay ratio of 35:1 for fiscal 2025, against median employee compensation of $278,074.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Raj Beri
Chief Operating Officer
◇◇◇◇——◇◇
Karsten Voermann
Chief Financial Officer
◇◇◇———◇◇
Romin Nabiey
Chief Accounting Officer
◇—◇◇◇—◇◇
Babak Azad
Chief Marketing Officer and SVP, Marketing & Communications
◇—◇—◇—◇◇
Trevor Bezdek
Co-Chief Executive Officer
◇◇————◇◇
Douglas Hirsch
Co-Chief Executive Officer
◇—————◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Wagner
Former Interim Chief Executive Officer
Served on an interim basis
◇◇—◇——◇◇
Bansi Nagji
Former President, Healthcare
Departed during or after this year
◇◇◇◇——◇◇
Romin Nabiey
Chief Accounting Officer and Former Interim Chief Financial Officer
◇◇◇◇◇—◇◇
Karsten Voermann
Former Chief Financial Officer
◇◇——◇—◇◇
Trevor Bezdek
Co-Chairman of the Board
◇◇——◇—◇◇
Douglas Hirsch
Chief Mission Officer
◇———◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Wagner
Former Interim Chief Executive Officer
Served on an interim basis
◇◇◇◇◇—◇◇
Karsten Voermann
Former Chief Financial Officer
◇◇◇◇◇—◇◇
Raj Beri
Former Chief Operating Officer
Departed during or after this year
◇——◇——◇◇
Romin Nabiey
Chief Accounting Officer and Former Interim Chief Financial Officer
◇◇◇◇◇—◇◇
Trevor Bezdek
Co-Chairman of the Board
◇◇——◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Wendy Barnes
Chief Executive Officer & President
◇◇◇◇——◇◇
Christopher McGinnis
Chief Financial Officer & Treasurer
◇◇◇◇——◇◇
Romin Nabiey
Chief Accounting Officer and Former Interim Chief Financial Officer
◇◇◇◇◇—◇◇
Trevor Bezdek
Co-Chairman of the Board
◇◇◇———◇◇
Scott Wagner
Former Interim Chief Executive Officer
Departed during or after this year
◇—◇———◇◇
Karsten Voermann
Former Chief Financial Officer
Departed during or after this year
◇——◇——◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Christopher McGinnisRSU◇——◇——◇
Christopher McGinnisOPTION◇——◇—◇◇
Karsten VoermannOPTION◇——◇—◇◇
Karsten VoermannOPTION◇——◇—◇◇
Romin NabieyOPTION◇——◇—◇◇
Romin NabieyRSU◇——◇——◇
Scott WagnerRSU◇——◇——◇
Scott WagnerRSU◇——◇——◇
Scott WagnerRSU◇——◇——◇
Trevor BezdekRSU◇——◇——◇
Trevor BezdekRSU◇——◇——◇
Wendy BarnesRSU◇——◇——◇
Wendy BarnesOPTION◇——◇—◇◇
Wendy BarnesRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Scott WagnerRSU◇◇——
RSU◇◇——
Romin NabieyRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇05/30/2033
RSU◇◇——
Option◇—◇03/12/2034
Option◇—◇09/22/2032
Option◇—◇03/05/2035
Christopher McGinnisRSU◇◇——
Option◇—◇03/03/2035
Trevor BezdekRSU◇◇——
RSU◇◇——
Wendy BarnesRSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Karsten Voermann
Former Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
Severance cash amount◇
Equity acceleration on change in control◇
Excise tax treatment◇
Romin Nabiey
Chief Accounting Officer and Former Interim Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
Change-in-control trigger◇
Equity acceleration on change in control◇
Scott Wagner
Former Interim Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
Severance cash amount◇
Equity acceleration on change in control◇
Excise tax treatment◇
Trevor Bezdek
Co-Chairman of the Board · Terms as described in the company’s compensation discussion · citing a 2025 filing
Change-in-control trigger◇
Equity acceleration on change in control◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Trevor Bezdek
◇—————◇
Scott Wagner
◇————◇◇
Ian T. Clark
◇◇————◇
Ronald E. Bruehlman
◇◇————◇
Agnes Rey-Giraud
◇◇————◇
Kelly J. Kennedy
◇◇————◇
Douglas Hirsch
◇◇————◇
Wendy Barnes
◇—————◇
Dipanjan Deb, Gregory Mondre, Julie Bradley and Christopher Adams served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • 23andMe Holding Co. ME
  • Accolade, Inc. ACCD
  • Affirm Holdings, Inc. AFRM
  • Alarm.com Holdings, Inc. ALRM
  • Alignment Healthcare, Inc. ALHC
  • AppFolio, Inc. APPF
  • Asana, Inc. ASAN
  • Box, Inc. BOX
  • CarGurus, Inc. CARG
  • Certara, Inc. CERT
  • Doximity, Inc. DOCS
  • EngageSmart, Inc. ESMT
  • EverCommerce, Inc. EVCM
  • HealthEquity, Inc. HQY
  • Hims Hers Health, Inc. HIMS
  • LegalZoom.com, Inc. LZ
  • Marqeta, Inc. MQ
  • MultiPlan Corp. symbol not shown
  • Nextgen Healthcare, Inc. NXGN
  • Phreesia, Inc. PHR
  • Premier, Inc. PINC
  • Privia Health Group, Inc. PRVA
  • Progyny, Inc. PGNY
  • Q2 Holdings, Inc. QTWO
  • Sharecare, Inc. SHCR
  • Squarespace, Inc. SQSP
  • Teladoc Health, Inc. TDOC
  • Vertex, Inc. VERX
  • ZipRecruiter, Inc. ZIP

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 16, 2026=◇◇◇
2024June 3, 2025=◇◇◇
2023June 6, 2024=◇◇◇
2022June 14, 2023=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Wendy Barnes (Chief Executive Officer & President), FY2025 total compensation $23,367,483 (base salary $825,000) [exec_comp, SEC accession 0001809519-26-000091, filed 2026-04-29]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when GoodRx Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact GoodRx Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where GoodRx Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether GoodRx Holdings' disclosed peer group is defensible, who names GoodRx Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
263 figures on this page: 259 cited to the filing that reported them, 4 calculated from figures it prints.
259 cited to the filing
4 calculated from the filing

Documents cited

  1. 0001809519-26-000133
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001809519-26-000091
    Chief Executive Officer Pay Ratio · DIRECTOR COMPENSATION · GRANTS OF PLAN-BASED AWARDS · OUTSTANDING EQUITY AWARDS AT YEAR-END · and 1 more section
  3. 0001809519-25-000088
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001809519-25-000063
    Compensation Discussion and Analysis · SUMMARY COMPENSATION TABLE
  5. 0001809519-24-000104
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001809519-24-000062
    SUMMARY COMPENSATION TABLE
  7. 0000950170-23-028633
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000950170-23-016311
    SUMMARY COMPENSATION TABLE
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “GoodRx Holdings executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/GDRX (accessed 2026).
Short form: data: Velarion

The paid brief for GoodRx Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about GoodRx Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Tech — Software rankings

Chief executive pay — Tech — SoftwareCEO pay ratio — Tech — SoftwareSay-on-pay support — Tech — Software

Peers GoodRx Holdings discloses

The companies named in GDRX's own disclosed peer group.

23andMe Holding Co.Accolade, Inc.Affirm Holdings, Inc.Alarm.com Holdings, Inc.Alignment Healthcare, Inc.AppFolio, Inc.Asana, Inc.Box, Inc.CarGurus, Inc.Certara, Inc.Doximity, Inc.EngageSmart, Inc.EverCommerce, Inc.HealthEquity, Inc.Hims Hers Health, Inc.LegalZoom.com, Inc.Marqeta, Inc.Nextgen Healthcare, Inc.Phreesia, Inc.Premier, Inc.Privia Health Group, Inc.Progyny, Inc.Q2 Holdings, Inc.Sharecare, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy